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Physical activity and exercise training play an important role in the clinical management of patients with cystic fibrosis (CF).
Exercise training is more common and recognized as an essential part of rehabilitation programmes and overall CF care. Regular
exercise training is associated with improved aerobic and anaerobic capacity, higher pulmonary function, and enhanced airway
mucus clearance. Furthermore, patients with higher aerobic fitness have an improved survival. Aerobic and anaerobic training
may have diﬀerent eﬀects, while the combination of both have been reported to be beneficial in CF. However, exercise training
remains underutilised and not always incorporated into routine CF management. We provide an update on aerobic and anaerobic
responses to exercise and general training recommendations in children and adolescents with CF.We propose that an active lifestyle
and exercise training are an eﬃcacious part of regular CF patient management.
1. Introduction
Physical activity and exercise training have become increas-
ingly important and widely accepted as part of therapy
and rehabilitation programmes in cystic fibrosis (CF) man-
agement. Physical activity refers to any body movement
produced by the skeletal muscles and occurs in a vari-
ety of forms (i.e., free play, exercise, organised sports),
resulting in a substantial increase in energy expenditure
[1]. Exercise training, however, can be defined as regu-
lar participation in vigorous physical activity to improve
physical performance or cardiovascular function or muscle
strength or any combination of these three [2]. Prior to
initiation of any exercise training, detailed exercise testing
is recommended, not only to monitor disease progression,
but also to detect exercise-induced limitations and therefore
to provide the patients with safe training recommenda-
tions [3, 4]. Ideally, exercise training should complement
current therapies in CF patient healthcare. In previous
reports, however, it has emerged that clinicians lack specific
recommendations to instruct their patients appropriately
[5, 6].
Several studies report beneficial eﬀects of exercise train-
ing on cardiopulmonary fitness (CPF) in patients with CF
[7–11]. CPF pertains to the functions of both the heart and
the pulmonary system, usually expressed as peak oxygen
consumption (peak V˙O2), themost reliable and reproducible
measure of CPF following maximal exercise testing [12].
Recently, Bradley and Moran examined the eﬀectiveness of
exercise training in CF using a systematic Cochrane review
[13]. Seven randomised controlled trials with a total number
of 231 participants were included, investigating the eﬀects of
diﬀerent types of training (aerobic versus anaerobic training,
anaerobic training, aerobic training, and the combination
of both). The authors conclude that exercise training is an
important part of CF care; however, there are insuﬃcient
numbers of studies published to date to document the
benefits of exercise training for people with CF. Nevertheless,
the authors state that there is no evidence to actively
discourage exercise training [13]. In 2009 Wilkes et al.
underlined the importance of exercise and habitual physical
activity in children with CF [14]. In particular, Wilkes et
al. highlighted that education of health care providers and
implementing exercise in clinical practice are needed [14].
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Regular exercise training may improve pulmonary function,
increase aerobic and anaerobic capacity, strengthen ventila-
tory muscles, and help airway sputum clearance, the latter
probably due to enhanced ventilation and vibrations during
exercise, leading to mechanical airway clearance [7, 8, 11, 15–
19]. Furthermore, it is suspected that moderate intensity
exercise blocks the amiloride-sensitive sodium channels of
the respiratory epithelium, thus resulting in lower mucus
viscosity, simplifying mucus expectoration [20]. Moreover,
higher activity levels and peak V˙O2 are positively related to
survival in CF [21–23]. Types of training (aerobic versus
anaerobic) may have diﬀerent eﬀects on improvement in
exercise tolerance [13], but most training studies so far have
focused on endurance training, observing improvements in
pulmonary function, peak V˙O2, breathlessness, and quality
of life [11, 18, 19, 24]. Exercise training including anaerobic
(strength) exercises can improve muscle strength and muscle
size, resulting in weight gain [16, 19, 25]. Therefore, a com-
prehensive training programme should include a variety of
sports activities, adapted to the special needs and preferences
of each individual. However, the eﬀects of training most
likely depend on the trainingmethods, as improvements may
only persist with continuous training in the long term. The
aim of this paper is to provide a focused update on aerobic
and anaerobic responses to exercise and habitual physical
activity exclusive to children and adolescents with CF. This
paper will help to strengthen the rationale for the initiation of
further clinical trials examining the eﬀects of regular exercise
on overall health in the paediatric CF population.
2. Method of Review
All relevant studies for this paper were identified using
electronic search of Medline and PubMed databases. A
bibliography search of all accessed publications was also
performed. Key descriptors were cystic fibrosis, training,
rehabilitation, aerobic fitness, children, and adolescents. The
selection of studies presented in the paper was based upon
the agreement by all four authors. We include studies of
subjects with CF, independently of their disease severity,
and type of exercise training (aerobic training; anaerobic
training; combination of aerobic and anaerobic training, as
well as inspiratory muscle training).
2.1. Physiological Responses to Exercise in Children and
Adolescents with Cystic Fibrosis. Physical activity is a fun-
damental part of the growth and development of children.
Neither any physical activity nor an exercise task can be
considered as solely aerobic or anaerobic. The nature of a
child’s activity requires an interplay of both aerobic and
anaerobic metabolism. An update on aerobic and anaerobic
performance in children with CF is outlined below.
2.1.1. Aerobic Responses to Exercise. Aerobic exercises include
any kind of activities using large muscle groups that can be
maintained continuously in a rhythmic manner (e.g., swim-
ming, cycling, or running). Activities with moderate eﬀort
can be performed over hours without significant decline in
exercise performance (although there is some variation on
individuals’ physical fitness, energy intake during exercise,
etc.). Aerobic capacity of children with CF over a long
period of time is less researched, indicating the dearth of
data regarding longitudinal assessment of peak V˙O2. Klijn
et al. investigated the longitudinal relationship between
peak V˙O2, pulmonary function, and body composition in
65 children with mild CF lung disease (10.5 ± 2.9 years
of age; forced expiratory volume in 1 s (FEV1) 92.6 ±
20.5% predicted) over two years. The authors found that
longitudinal changes in lung function were associated with
functional changes in peak V˙O2 and to a lesser extent with
fat free mass (FFM). While FFM is a critical determinant
of maximal exercise capacity, FFM may be important for
maintaining overall functional capacity and to improve long-
term outcome in CF [26, 27]. Peak V˙O2 during maximal
exercise is an established prognostic marker in CF [21–23].
In particular, longitudinal data of peak V˙O2 in children
with CF indicate a decline in peak V˙O2 over time; however,
those with higher peak V˙O2 values have a prolonged survival
[23]. In comparison to healthy subjects, children with CF
show reduced maximal exercise performance, decreased
respiratory function, malnutrition, and physical inactivity as
well as intrinsic abnormalities of the skeletal muscle, all likely
to be contributing factors [28, 29]. Diminished eﬃciency
of mitochondrial oxidative Adenosine Triphosphate (ATP)
synthesis or abnormalities in myofibril mechanics may also
aﬀect maximal exercise capacity in CF [26, 30]. It has also
been reported that peak V˙O2 and early oxygen consumption
(V˙O2) recovery are significantly related in children with
chronic lung disease, implying that the greater the aerobic
fitness, the faster the rate of recovery following exercise [31].
Hebestreit et al. reported slower V˙O2 kinetics at the onset of
exercise in children with CF compared to healthy children,
probably due to an impairment in oxygen delivery [32].
CF lung disease is often associated with physical inactiv-
ity and deconditioning. Improvements in CPF require indi-
vidual dosages of training stimuli and vary among individ-
uals. However, the optimal training modes for patients with
CF have not yet been identified. It has been demonstrated
that the time spent on physical activity in children with CF
is similar to that of healthy children, but healthy children
spend more time exercising at vigorous intensities [33]. In
contrast, Selvadurai et al. observed diﬀerences in activity
behaviours between prepubertal and pubertal children with
CF of diﬀerent stages of disease severity and their healthy
peers using accelerometry and activity diaries. Prepubertal
and pubertal children with mild CF lung disease were
more active compared to their healthy controls. Interestingly,
between prepubertal children with moderate-to-severe CF
lung disease and a control group no diﬀerences were found.
Gender diﬀerences occurred between pubertal girls and
boys with CF, as girls’ habitual physical activity levels were
significantly lower. However, compared to healthy controls,
pubertal children with moderate to severe CF disease were
significantly less active [34]. Gender diﬀerences in habitual
physical activity levels between healthy girls and boys are well
known, not only when comparing to chronically diseased
children [35, 36].
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Several studies investigating the eﬀects of exercise train-
ing and rehabilitation programmes in CF showed increased
peak V˙O2 and peak minute ventilation (peak V˙E) values,
and reduced heart rates (HR) at submaximal workloads,
indicating improved CPF [11, 16, 19, 25, 37]. Interestingly,
the observed training eﬀects are independent of patients’
disease severity. Thus, even patients with severe CF lung
disease are able to improve their CPF. Furthermore, it has
been established that children with CF had higher activity
levels, greater aerobic fitness, enhanced nutritional status,
and significantly lower progression of disease [34].
Gulmans et al. investigated the eﬀects and acceptability
of a 6-month home-based cycling programme in 14 children
(age 14.1 years) with mild-to-moderate CF lung disease [38].
The programme consisted of 5 ergometer cycling sessions per
week for 20min each with the training intensity progressively
increasing over time. In the first week the training intensity
started at 50% of maximal workload, increasing up to 60%
in the following weeks until the next measurement was up
to 70% of maximal workload. Once a week, the programme
was supervised by a physiotherapist. HR was measured
every three minutes, and the workload was adjusted to
reach target training intensities between 140–160 beats per
minute (70%–80% of predicted maximal). After the training
period, peak V˙O2 per kg body mass as well as per kg FFM
increased significantly. Moreover, leg muscle strength for
knee extensors and ankle dorsiflexors significantly increased
during the training period. Unfortunately, the acceptability
of the programme was low, probably due to the somewhat
“monotonous” cycling programme. In general, adherence
to treatments is challenging in CF, especially adherence to
regular exercise and physical activity. However, the participa-
tion in the prescribed exercise training programme has been
shown to increase perceived competence and self-esteem in
the children as important mediators to adherence behaviour.
This seems of particular relevance for patients in terms of
maintaining an active lifestyle and adherence to training into
the long term. We suggest a training programme that should
focus on the individual interests of the children including
preferences for sport activities. The study may have benefited
by including diﬀerent activities to maintain motivation and
adherence to training [38].
Furthermore, in a 12-week randomised and controlled
study following a standardised anaerobic training pro-
gramme in eleven children with CF, a significant increase in
peak V˙O2 (mL·min−1) in the training group was observed.
The supervised training consisted of two 30–45 min exer-
cise sessions per week of special anaerobic exercises, for
example, sprints, chest passes, exchange runs, and so forth.
all performed at near maximum intensities. The detailed
training programme can be found elsewhere: (http://www
.chestjournal.org/content/full/125/4/1299/DC1). In contrast,
peak V˙O2 was significantly decreased in the control group
(N = 9). After a 12-week follow up all parameters concerning
aerobic fitness decreased to pretraining levels [16].
Schneiderman-Walker et al. investigated the long-term
eﬀects of regular exercise training in a 3-year study. Children
and adolescents with mild to moderate CF lung disease aged
7–19 years were randomly assigned to either an exercise
intervention or control group. The exercise group was
instructed to perform a minimum of 20 minutes in their
favourite endurance-related activities three times per week.
In addition, the patients were advised to monitor their
HR while exercising at a training intensity of 70%–80% of
maximum HR. Evaluation of training and monitoring was
done during telephone and clinical conversations. Exercise
capacity was measured during cycle ergometry. At the end
of the intervention, no significant diﬀerences in the annual
rate of decline in peak V˙O2, peak heart rate (peak HR),
and peak V˙E between either group were found. However,
the intervention group demonstrated a significantly lower
annual decline in FEV1 and vital capacity (VC). Patients
in the exercise group remained compliant during the study
period and reported better well-being [18].
2.1.2. Anaerobic Responses to Exercise. Anaerobic activities
are characterised by high intensities of short durations
(lasting typically up to 30 s), being predominantly fuelled
by nonoxidative sources of ATP resynthesis. Previous studies
investigating anaerobic performance of children and adults
with CF showed lower values compared to healthy subjects
[39–41]. Furthermore, children with CF with higher levels of
habitual activity have been found to possess increased anaer-
obic power during the Wingate Anaerobic Test (WAnT).
These higher levels of activity are likely influenced by several
factors such as the extent of malnutrition, muscle mass,
mitochondrial abnormalities, and CF genotype [29, 30, 34,
40, 42, 43].
Boas et al. found lower power outputs in the WAnT in 41
male adolescents with CF compared to healthy controls [42].
Subgroup analysis of subjects with CF revealed that nutri-
tional status and sexual maturation rather than pulmonary
function may aﬀect anaerobic exercise performance. In
their observation, subjects with higher salivary testosterone
(>4.0 ng·dL−1) had higher power outputs in both absolute
terms and relative to lean body mass compared to subjects
and lower salivary testosterone values (<4.0 ng·dL−1). Fur-
thermore, bodymass index (BMI) was associated with higher
anaerobic performance, indicating higher power output
values. Categorising the patients regarding their pulmonary
function showed no diﬀerences, however, this population
had almost normal lung function values (FEV1, 90.2± 24.2%
predicted).
Another study showed significant improvements in
anaerobic parameters in the WAnT following a 12-week
individualised anaerobic training programme. Eleven chil-
dren with CF lung disease trained 30–45 minutes two times
per week. Peak power and mean power per kilogram FFM
significantly increased in the training group, as anaerobic
parameters did not change in the control group. After a 12-
week followup period, anaerobic performance and quality of
life remained improved whereas most outcome parameters
decreased to pretraining levels [16].
In another related study, Selvadurai et al. investigated
the relationship between fitness and CF genotype in 79
children with a wide range of disease severity. The class of
CF transmembrane conductance regulator (CFTR)mutation
was significantly correlated with anaerobic and aerobic
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performance, BMI, and pulmonary function. Patients with
class I and II CFTR mutation had the lowest peak anaerobic
power in the WAnT compared to those with classes III, IV,
and V CFTR mutations, respectively [43].
Unfortunately, most training studies in CF are of short
duration, and longitudinal data are lacking, especially in the
paediatric population. Longitudinal and controlled studies
are required to verify training eﬀects in association with
disease progression in CF and decline in pulmonary function
and peak V˙O2. Studies, documenting less or no eﬀects after
exercise training on CPF, are most likely due to a low number
of study subjects, lack of a control group or lack of training
supervision, and poor compliance [25, 44]. Further research
is warranted to assess the eﬀects of diﬀerent trainingmethods
longitudinally (aerobic versus anaerobic training versus a
combination of both training regimes). More detailed infor-
mation regarding training protocols (intensity, duration, and
rest periods) would be advantageous to therapists and health
care providers working with children with CF. Furthermore,
when working with children the fun component needs to
be emphasised, while group activities may be the preferred
choice rather than isolated training (i.e., cycling or stepping),
infection control permitting. Trampolining, for example, as
a popular although controversial activity, has been discussed
in the paediatric population and CF lung disease, especially
due to the increased risk potential for injuries [45–47].
However, providing there is particular focus on safety issues
and supervision, trampolining can be an eﬀective adjunct
to regular airway clearance techniques or even as part of
physiotherapy in CF [48]. In habitual daily life patients with
CF are faced with certain barriers and challenges according to
their participation in regular exercise and habitual physical
activity [14]. Parents should be encouraged to exercise
with their children and serve as role models (i.e., aiming
to increase habitual physical activity levels). Based on the
training studies available in children and adolescents with
CF, there is no definitive evidence regarding the sustainability
of training eﬀects in the long term (i.e., months to years).
2.2. Possible Risks Associated with Exercise Training in CF.
Specific risks of exercise training in CF are presented in
the table. During prolonged exercise, as a consequence
of excessive sweat and sodium losses, children with CF
are advised to drink repeatedly (i.e., every 15–20min),
and ideally including approximately 50mmol·L−1 sodium
chloride in their drink [49]. Especially, in hot conditions,
children may underestimate their fluid needs with the risk
to undergo excessive dehydration [50].
Certain sports in this population should also be viewed
with caution. For example, CF patients with portal hyper-
tension with significant enlargement of spleen and liver
should, as a precaution, be advised against participation in
contact sports. Patients participating in physical activities
which take place at high altitudes (e.g., skiing) should
be monitored, especially if the patient is already hypoxic.
Furthermore, episodes of acute right heart failure induced
by a combination of altitude and high intensity exercise have
been documented [51]. During diving activities air trapping
could occur in patients with lung disease, on ascent the air
Table 1: General exercise and training recommendations.
Patients with mild to
moderate CF lung
disease
Patients with severe
CF lung disease
Recommended
activities
Cycling, walking,
hiking, aerobics,
running, rowing,
tennis, swimming,
strength training,
climbing,
roller-skating,
(trampolining)
Ergometric cycling,
walking,
strengthening
exercises, gymnastics,
and day-to-day
activities
Method
Intermittent and
steady-state
Intermittent
Frequency 3–5 times per week 5 times per week
Duration 30–45 minutes 20–30 minutes
Intensity
70%–85% HRmax;
60%–80% peak V˙O2;
LT; GET
60%–80% HRmax;
50%–70% peak V˙O2;
LT; GET
Oxygen
supplementation
Indicated, if SaO2
drops below 90%
during exercise
Indicated, if SaO2
drops below 90%
during exercise (cave:
resting hypoxia)
Activities to avoid
Bungee-jumping, high
diving, and scuba
diving
Bungee-jumping,
high diving, scuba
diving, and hiking in
high altitude
Potential risks
associated with
exercise, and
training
Dehydration
Hypoxemia
Bronchoconstriction
Pneumothorax
Hypoglycaemia∗
Hemoptysis
Oesophageal bleedings
Cardiac arrhythmias
Rupture of liver and spleen
Spontaneous fractures∗∗
HRmax: maximum heart rate; peak V˙O2: peak oxygen consumption; LT:
lactate threshold; GET: gas exchange threshold; SaO2: oxygen saturation.
∗Depending on the existence of an impaired glucose tolerance.
∗∗Depending on the existence of untreated CF-related bone disease.
expands, with risk of development of pneumothorax [52].
Exercise-induced hypoxemia is a potential hazard for patients
with CF, thus participation in high-intensity exercise needs
consideration. However, soon after the termination of high
intensity eﬀorts, SaO2 returns to pre-exercise levels, while
there is no evidence that brief exercise-induced hypoxemia
causes damage to the child with CF [53]. Cough with sputum
may be observed during exercise in patients; however, this is
indicative of airway clearance.
General guidelines for clinical exercise testing [54, 55]
and training in patients with chronic disease are beyond
the scope of this paper and can be found elsewhere [49].
The table summarises a selection of recommended exercises,
including training intensities for patients with CF. The
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optimal training mode for CF patients has yet to be defined.
Our recommendations (see Table 1) are based on training
studies available, as well as, our own clinical and practical
experience in the work with children and adolescents with
CF. We support the approach of combining endurance
and strengthening activities as well as exercises to improve
flexibility, balance, and motor skills [7]. In addition to
exercise training, an active lifestyle is generally recommended
to improve exercise capacity, for example, using stairs
instead of an elevator. We therefore recommend including
a detailed description of training methods and parameters
(duration, intensity, frequency, and rest periods) in future
studies. In particular, this may help comparing results of
diﬀerent training studies. Despite the beneficial eﬀects of
regular (structured) exercise, habitual physical activity levels
(activities that can easily incorporated in daily life) have been
shown to contribute to the overall health in children with CF.
3. Conclusion
Physical activity is well recognized as part of health care
and rehabilitation programmes in CF; however the relation-
ships between activity, fitness, and health are still poorly
understood. Higher levels of habitual activity have been
associated with higher aerobic and anaerobic capacity, a
better quality of life, and improved survival. However,
longitudinal studies are needed to support and justify
programmes of regular exercise on the overall health status
of children and adolescents with CF. To date, there is no
evidence that children and adolescents with CF should not
be physically active in daily life. Moreover, as part of their
CF management, it would be desirable to inform patients,
and their parents about the beneficial eﬀects of exercise, but
also its potential risks, and additionally provide patients with
training recommendations. Ideally, these would be based
on previously performed standard clinical exercise testing.
It is necessary to instruct clinicians, health care support
staﬀ, patients and parents regarding adequate exercises and
sports activities during rehabilitation programmes that can
be implemented in normal daily life.
Abbreviations
CF: Cystic fibrosis
CPF: Cardiopulmonary fitness
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HR: Heart rate
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BMI: Body mass index
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